Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., F.C.P.S (Medicine)
Diabetologist
M.B.B.S, M.P.H., M.C.P.S
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Pulmonologist
MBBS, MRCP, FRACP, M.P.H., FACP (USA), FCCP (USA)
Internal Medicine Specialist
M.B.B.S., MCPS (Pulomonlogy), MRCGP (UK), F.C.P.S., MARH
Internal Medicine Specialist
M.B.B.S., MCPS (Pulomonlogy), MRCGP (UK), F.C.P.S., MARH
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Family Physician
M.B.B.S, M.C.P.S (Medicine)
Oncologist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Medical Oncology)
Internal Medicine Specialist
MBBS, MCPS, MRCGP
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), M.R.C.P. (Uk), F.R.C.P. (London)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), M.R.C.P. (Uk), F.R.C.P. (London)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures